Join the club for FREE to access the whole archive and other member benefits.

How DNA sequencing is transforming the hunt for new drugs

13-May-2015

Key points from article :

Pharmaceuticals companies analysings hundreds of thousands of DNA samples to identify new gene targets. Previously took decades to find and study enough people with rare traits.

Mentioned in this article:

Click on resource name for more details.

Eric Topol

Founder and director of the Scripps Research Translational Institute, American cardiologist, scientist and author

Geisinger

Pennsylvania’s Health System.

Regeneron Pharmaceuticals

Biotechnology company

Topics mentioned on this page:
AI in Healthcare, DNA Testing